Reference Price System faced challenges all around.

Published: 2002-09-04 07:00:00

Updated: 2002-09-04 07:00:00

Many civic groups and other relevant organizations like the KPhA and KMA rejected unanimously the current government's drug pricing policy "Reference Price System", claiming that it hampers providing better medical services and rather passes heavier financial burdens to patients.

They all welc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK